Validation of ICG to Identify the Urethra During Rectal Surgery

• Status: Terminated
• Trial end date: 2018-08-01
• Target enrollment: 0
• Participant gender: Male

Summary

This is an open-label feasibility study utilising direct instillation of ICG into the urethra during surgery for low rectal cancers. The trial involves a single intervention taking place during the patient's operation. Participants will be included in the study for around 2 months with time either side of the intervention to collect background data.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Oxford University Hospitals NHS Trust
• Collaborator: University of Oxford

Criteria

Inclusion Criteria:

• Participant is willing and able to give informed consent for participation in the study.

• Male, aged 18 years or above.

• Undergoing low rectal surgery where the operating field will be close to the urethra

Exclusion Criteria:

• Participant has an allergy to iodine or ICG

• Known liver failure